senior management Archives

Johnson & Johnson has appointed Joaquin Duato as chief executive officer to replace long-serving Alex Gorsky, who has

Alex Gorsky will pass leadership of J&J to Joaquin Duato in January

https://pharmaphorum.com/news/alex-gorsky-will-pass-leadership-of-jj-to-joaquin-duato-in-january/

News/ News/ R&D

With Alzheimer’s market opening up, Lilly forms neuroscience unit

Phil Taylor donanemab, Eli Lilly, immunology, neuroscience, R&D, senior management 0 Comment

Eli Lilly is one of the front runners in the bid to follow Biogen and Eisai onto the

With Alzheimer’s market opening up, Lilly forms neuroscience unit

https://pharmaphorum.com/news/lilly-forms-neuroscience-unit/

News/ News/ Sales and Marketing

GSK names McNamara as CEO of consumer health spinout

Phil Taylor consumer health, GlaxoSmithKline, senior management 0 Comment

GlaxoSmithKline has said that Brian McNamara – currently head of its three-year-old consumer health joint venture with Pfizer

GSK names McNamara as CEO of consumer health spinout

https://pharmaphorum.com/news/gsk-names-mcnamara-as-ceo-of-consumer-health-spinout/

News/ News/ Oncology

Arcus’ CMO Grossman jumps ship to join Gilead’s cancer push

Phil Taylor Arcus Biosciences, clinical research, Gilead Sciences, immuno-oncology, Oncology, senior management 0 Comment

Gilead Sciences just forged even closer ties with its cancer drug partner Arcus Biosciences, enticing the biotech’s chief

Arcus’ CMO Grossman jumps ship to join Gilead’s cancer push

https://pharmaphorum.com/news/arcus-cmo-grossman-jumps-ship-to-join-gileads-cancer-push/

News/ News/ Oncology

GSK cancer head Hoos exits, takes top role at biotech Scorpion

Phil Taylor GlaxoSmithKline, immuno-oncology, Oncology, Scorpion Therapeutics, senior management 0 Comment

GlaxoSmithKline’s head of oncology Axel Hoos has resigned from the company, and will take up a new role

GSK cancer head Hoos exits, takes top role at biotech Scorpion

https://pharmaphorum.com/news/gsk-cancer-head-hoos-exits-takes-top-role-at-biotech-scorpion/

News/ News/ R&D

GSK backs CEO Walmsley, rejecting Elliott’s call to change board

Phil Taylor consumer health, Elliott Management, Emma Walmsley, GlaxoSmithKline, senior management 0 Comment

GlaxoSmithKline’s board had responded to the broadside attack delivered by activist investor Elliott Management yesterday, saying it stands

GSK backs CEO Walmsley, rejecting Elliott’s call to change board

https://pharmaphorum.com/news/gsk-backs-ceo-walmsley-rejecting-elliotts-call-to-change-board/

News/ News/ Sales and Marketing

Elliott fires broadside at GSK in wake of investor update

Phil Taylor consumer health, Elliott Management, Emma Walmsley, GlaxoSmithKline, senior management, vaccines 0 Comment

GlaxoSmithKline chief executive Emma Walmsley was no doubt hoping that an upbeat assessment of the firm’s prospects at

Elliott fires broadside at GSK in wake of investor update

https://pharmaphorum.com/news/elliott-fires-broadside-at-gsk-in-wake-of-investor-update/

Market Access/ News/ News

Consumer group seeks resignation of top FDA staffers over Aduhelm okay

Phil Taylor aducanumab, Aduhelm, Alzheimer's disease, Biogen, central nervous system, fda, Janet Woodcock, neurology, senior management 0 Comment

With the first patient set to receive Biogen’s new Alzheimer’s drug Aduhelm in Rhode Island today, US consumer

Consumer group seeks resignation of top FDA staffers over Aduhelm okay

https://pharmaphorum.com/news/consumer-group-seeks-resignation-of-top-fda-staffers-over-aduhelm-okay/

News/ News/ R&D

Slaoui exits three more companies amid harassment fallout

Phil Taylor Centessa, Medicxi, Moncef Slaoui, R&D, senior management, Vaxcyte 0 Comment

Moncef Slaoui has stepped down from positions at three more companies, shortly after being dismissed from a firm

Slaoui exits three more companies amid harassment fallout

https://pharmaphorum.com/news/slaoui-exits-three-more-companies-amid-harassment-fallout/

Trending

senior management

Login